类风湿关节炎患者血浆代谢组学与主要不良心血管事件
小HDL颗粒浓度及脂质含量较高与MACE风险降低相关,富含甘油三酯及残粒样脂蛋白指标较高与风险升高相关,且部分关联为RA患者特有。
要点
- 小HDL颗粒浓度及脂质含量较高与RA患者MACE风险降低相关。
- 富含甘油三酯及残粒样脂蛋白指标较高与RA患者MACE风险升高相关。
- RA患者具有独特的代谢组学心血管风险特征,部分关联与对照不同。
核心结论
- 在RA患者中识别出独特的心血管风险代谢组学特征,小HDL颗粒与较低MACE风险相关,大HDL颗粒与较高风险相关。
研究设计与样本
- 研究纳入1271例无已知心血管疾病且采血时未使用他汀的Mass General Brigham Biobank类风湿关节炎患者,采用1H NMR代谢组学定量168种代谢物,并与1:2匹配的非RA对照队列比较。
主要发现
- 平均年龄62岁,80%为女性,中位随访7.8年期间8%发生MACE。
- 小HDL颗粒浓度及脂质含量较高、循环白蛋白及部分氨基酸较高主要与较低MACE风险相关。
- 富含甘油三酯及残粒样脂蛋白指标较高与MACE风险升高强烈相关。
- 与对照相比,部分关联为RA患者特有,涉及富含甘油三酯的VLDL和HDL颗粒。
临床怎么用
- 在RA患者心血管风险评估中可关注小HDL颗粒、富含甘油三酯脂蛋白及残粒样脂蛋白等代谢组学指标。
- 上述代谢特征可能为炎症靶向及HDL修饰治疗提供潜在方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Patients with RA have excess cardiovascular risk beyond traditional factors. We evaluated associations between plasma metabolites and incident major adverse cardiovascular events (MACEs) in RA and compared findings with matched controls. METHODS: We studied 1271 Mass General Brigham Biobank participants with RA, without known cardiovascular disease and no statin use at blood draw. 1H NMR metabolomics quantified 168 metabolites spanning lipoprotein particles and contents, fatty acids, amino acids and glycolysis. Incident MACE (myocardial infarction, stroke, transient ischaemic attack or death) was identified using ICD codes. Multivariable Cox models with false discovery rate correction assessed associations. Findings were compared with a 1:2 matched non-RA control cohort. RESULTS: The mean age was 62 years, 80% were women and 8% experienced incident MACE over a median follow-up of 7.8 years. Twenty-five plasma metabolites were significantly associated with MACE. Lower MACE risk was primarily associated with higher levels of small HDL particle concentration and lipid content, as well as circulating albumin and select amino acids. In contrast, higher MACE risk was strongly associated with triglyceride-rich and remnant-like lipoprotein measures. When compared with controls, several associations were unique to the RA patients, who demonstrated a distinct metabolomic risk profile, involving triglyceride-rich VLDL and HDL particles. CONCLUSION: In this first metabolomic study in RA, we identified a distinct cardiovascular risk profile. Higher levels of large HDL particles were associated with increased risk, whereas small HDL particles were associated with lower risk, with potential implications for inflammation-targeted and HDL-modifying therapies.
引用
- Kotanidis CP, Choksi P, Natarajan P, et al. Plasma metabolomics and incident major adverse cardiovascular events in patients with rheumatoid arthritis. Rheumatology (Oxford). 2026. PMID: 42538831. doi:10.1093/rheumatology/keag383
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。